Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.412
https://www.valueinhealthjournal.com/article/S1098-3015(16)31779-X/fulltext
Title :
Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31779-X&doi=10.1016/j.jval.2016.09.412
First page :
A418
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
388